Nasus PharmaNSRX
13F holders, Q3 2025 (September 30)2holders
$6.65avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Nasus Pharma Ltd. (NSRX) in their 13F filings. The largest holders were Morgan Stanley ($13K) and UBS Group AG ($8K).
- Company
- Nasus Pharma Ltd.
- CUSIP
- M7071P109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $22K |
| Exits | 0 | $0 |
Ownership 2 holders
| Morgan Stanley | 0.00% | New | 2,000 | $13K |
| UBS Group AG | 0.00% | New | 1,241 | $8K |
"% of holder's portfolio" is NSRX's weight in each manager's 13F, not the share of Nasus Pharma Ltd. the manager owns.